FIORINAL CAPSULE

Šalis: Kanada

kalba: anglų

Šaltinis: Health Canada

Veiklioji medžiaga:

BUTALBITAL; CAFFEINE; ACETYLSALICYLIC ACID

Prieinama:

ARALEZ PHARMACEUTICALS CANADA INC

ATC kodas:

N02BA71

INN (Tarptautinis Pavadinimas):

ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS

Dozė:

50MG; 40MG; 330MG

Vaisto forma:

CAPSULE

Sudėtis:

BUTALBITAL 50MG; CAFFEINE 40MG; ACETYLSALICYLIC ACID 330MG

Vartojimo būdas:

ORAL

Vienetai pakuotėje:

100

Recepto tipas:

Schedule G (CDSA IV)

Gydymo sritis:

BARBITURATES

Produkto santrauka:

Active ingredient group (AIG) number: 0301241001; AHFS:

Autorizacija statusas:

APPROVED

Leidimo data:

2015-12-01

Prekės savybės

PRODUCT INFORMATION
FIORINAL
®
(acetylsalicylic acid-caffeine-butalbital)
Capsules
USP
Combination Analgesic
Aralez Pharmaceuticals Canada Inc.*
DATE OF REVISION:
6733 Mississauga Rd., Suite 800
June 7, 2023
Mississauga, Ontario
L5N 6J5
www.miravohealthcare.com
Submission Control No: 270273
*Doing business as (d/b/a) Miravo Healthcare
_ _
_ _
_Page 2 of 22_
PRODUCT INFORMATION
NAME OF DRUG
FIORINAL
®
(acetylsalicylic acid-caffeine-butalbital)
USP
THERAPEUTIC CLASSIFICATION
Combination Analgesic
ACTION AND CLINICAL PHARMACOLOGY
Pharmacologically, FIORINAL
®
(ASA-caffeine-butalbital) combines the analgesic properties of
acetylsalicylic acid (ASA) with the anxiolytic and muscle relaxant
properties of butalbital.
PHARMACOKINETICS:
The behaviour of the individual components is described below.
_ACETYLSALICYLIC ACID (ASA) _
ASA
is
a
salicylate
that
binds
to
the
cyclooxygenase
enzyme
leading
to
a
reduction
in
prostaglandin activity. The systemic availability of ASA after an oral
dose is highly dependent
on the dosage form, the presence of food, the gastric emptying time,
gastric pH, antacids,
buffering agents, and particle size. These factors affect not
necessarily the extent of absorption of
total salicylates but more the stability of ASA prior to absorption.
During the absorption process and after absorption, ASA is mainly
hydrolyzed to salicylic acid
and distributed to all body tissues and fluids, including fetal
tissues, breast milk, and the central
nervous system (CNS). Highest concentrations are found in plasma,
liver, renal cortex, heart, and
lung. In plasma, about 50% - 80% of the salicylic acid and its
metabolites are loosely bound to
plasma proteins.
_ _
_ _
_Page 3 of 22_
The clearance of total salicylates is subject to saturable kinetics;
however, first-order elimination
kinetics are still a good approximation for doses up to 650 mg. The
plasma half-life for ASA is
about 12 minutes and for salicylic acid and/or total salicylates is
about 3 hours.
The elimination of therapeutic doses is through the kidneys